IBBJ - Defiance Nasdaq Junior Biotechnology ETF (USD) (US26922A1491)

The Defiance Nasdaq Junior Biotechnology ETF seeks to track the performance of the Nasdaq Junior Biotechnology Index, a modified market capitalization weighted index that tracks the performance of junior companies, with a market capitalization that is less than $5 billion, listed on the Nasdaq, and classified as either biotechnology or pharmaceutical.

The Defiance Nasdaq Junior Biotechnology ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Defiance ETFs fund’s base currency is USD and the share class was registered 03.08.2020 with unique ISIN - US26922A1491. Main exchange is NASDAQ and ticker symbol is IBBJ. The total expense ratio is 0.45%. The Defiance Nasdaq Junior Biotechnology ETF (USD) pays dividends 1 time(s) per year.